Evaluation of the response to PRRSGard® administration in weaned pigs

dc.contributor.author Smith, C.
dc.contributor.author Chamba, F.
dc.contributor.author Pittman, J.
dc.contributor.author Rawal, Gaurav
dc.contributor.author Zhang, Jianqiang
dc.contributor.author Francisco, C.
dc.contributor.department Veterinary Diagnostic and Production Animal Medicine
dc.date 2020-04-04T00:22:06.000
dc.date.accessioned 2020-07-07T05:12:33Z
dc.date.available 2020-07-07T05:12:33Z
dc.date.copyright Wed Jan 01 00:00:00 UTC 2020
dc.date.embargo 2020-10-03
dc.date.issued 2020-03-01
dc.description.abstract <p>Porcine reproductive and respiratory syndrome virus (PRRSV) continues to cause significant economic and performance losses in swine production in the United States. Multiple practices have been employed in attempts to control the disease, including modified-live virus (MLV) vaccines to reduce clinical signs, viremia and lung lesions, which improve health and performance in pigs. There are several different PRRSV MLV products commercially available to producers. The choice between products may be influenced by cost, efficacy, decreased performance or setback directly following vaccination (drag), and the ability of the vaccine to spread to non-target or non-vaccinated pig populations.</p> <p>PRRSGard® is a unique PRRSV MLV vaccine with a chimeric virus composed from a proprietary, highly attenuated backbone and structural proteins from a highly virulent isolate (MN184) within ORF5 lineage 1. Additionally, a 23-nucleotide insert has been positioned between ORF1b and ORF2 to be used as a genetic marker for differential rRT-PCR diagnostic testing. The objective of this report is to summarize the immunological response, shedding profile, and production performance drag of weaned pigs vaccinated with PRRSGard®.</p>
dc.description.comments <p>This proceeding is published as Smith, C., F. Chamba, J. Pittman, G. Rawal, J. Zhang, and C. Francisco. "Evaluation of the response to PRRSGard® administration in weaned pigs." In <em>Proceedings of the 51st Annual Meeting of the American Association of Swine Veterinarians</em>. Atlanta, GA, USA. (2020): 189-191. Posted with permission.</p>
dc.format.mimetype application/pdf
dc.identifier archive/lib.dr.iastate.edu/vdpam_conf/5/
dc.identifier.articleid 1002
dc.identifier.contextkey 17207778
dc.identifier.s3bucket isulib-bepress-aws-west
dc.identifier.submissionpath vdpam_conf/5
dc.identifier.uri https://dr.lib.iastate.edu/handle/20.500.12876/91938
dc.language.iso en
dc.source.bitstream archive/lib.dr.iastate.edu/vdpam_conf/5/2020_RawalGaurav_EvaluationResponse.pdf|||Sat Jan 15 00:38:54 UTC 2022
dc.subject.disciplines Large or Food Animal and Equine Medicine
dc.subject.disciplines Veterinary Infectious Diseases
dc.subject.disciplines Veterinary Preventive Medicine, Epidemiology, and Public Health
dc.title Evaluation of the response to PRRSGard® administration in weaned pigs
dc.type article
dc.type.genre conference
dspace.entity.type Publication
relation.isOrgUnitOfPublication 5ab07352-4171-4f53-bbd7-ac5d616f7aa8
Original bundle
Now showing 1 - 1 of 1
103.62 KB
Adobe Portable Document Format